Elyon Cannabis

In August 2026, Elyon Cannabis concentrated almost entirely in two categories, with Pre-Roll carrying 53.11% share and Flower holding 46.89%, a split that tightened month over month as Pre-Roll fell 23.15% MoM while Flower declined a smaller 5.32% MoM. Year over year, both categories expanded units as indicated by price compression, with Pre-Roll up 1.05% YoY and Flower up 4.43% YoY, while the brand’s average price dropped 33.95% YoY to $12.54, implying a deliberate shift to value tiers. In New Jersey Pre-Roll, Elyon Cannabis sat at rank 38, indicating mid-pack presence even as category mix leans toward Pre-Roll and average Pre-Roll price sits at $8.17; the rank-position and MoM decline together imply overexposure to promotional elasticities. The pattern suggests Elyon Cannabis traded down on price to sustain YoY volume in both categories, but the sharper MoM contraction in Pre-Roll versus Flower signals a need to rebalance mix toward SKUs with steadier repeat dynamics.

The shift places Elyon Cannabis as a price-led participant in Pre-Roll and a relatively steadier, higher-ticket option in Flower, with the 23.15% MoM Pre-Roll pullback against a 5.32% MoM Flower dip implying that incremental gains are more defensible in Flower at current pricing. With Pre-Roll at 53.11% share but rank 38 in New Jersey, the mix skews toward a category where the brand’s position lags, while Flower’s 46.89% share paired with a 4.43% YoY rise suggests headroom to trade customers up without repeating the 33.95% YoY price compression. Net effect: reallocating emphasis from discount-heavy Pre-Rolls (−23.15% MoM) toward value-tier but margin-protective Flower (+4.43% YoY) can stabilize month-to-month volatility and lift rank by focusing on SKUs where price elasticity is lower.